EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter... | September 17, 2022

Related Keywords

Boston ,Massachusetts ,United States ,Canada ,Philippe Genereux ,Firas Zahr ,Konstantinosp Koulogiannis ,Megan Coylewright ,Paula Grayburn ,Jacobm Mishell ,Bernardj Zovighian ,Raj Makkar ,Edwards Lifesciences ,Lindad Gillam ,Instagram ,Linkedin ,Twitter ,Exchange Commission ,Prnewswire Edwards Lifesciences Corporation ,Youtube ,Securities Exchange ,Edwards Lifesciences Corporation ,Facebook ,Cardiovascular Research Foundation ,Lifesciences Corporation ,Transcatheter Cardiovascular Therapeutics ,Scott Lim ,Advanced Heart Valve Center ,Virginia Health System ,Prospective Registry ,Transcatheter Edge To Repair ,Complex Mitral Valve Anatomy ,Late Breaking Presenter ,Dive Session ,Ralph Stephan ,Bioprosthetic Valve Fracture ,Patients Undergoing Valve ,Failed Surgical Valves Using ,Ultra Valves ,Insights From Real World Data ,Life After Aortic Valve Replacement ,Edge To Repair ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Edwards Lifesciences Corporation Stock Exchange ,News ,Information ,Press Release ,022 ,Edwards ,Lifesciences ,Corporation ,Nnounced ,Results ,Rom ,Clasp ,The ,First ,Randomized ,Ontrolled ,Trial ,Hat ,Irectly ,Compares ,Two ,Ontemporary Ew Us28176e1082 ,